Akcea Therapeutics, Inc. Comprehensive Income
Akcea Therapeutics, Inc. reported Comprehensive Income of -$48.49 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2020-08-05
- Akcea Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-06-30 was -$48.49M.
- Akcea Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-03-31 was -$42.46M, a 254.50% decline year-over-year.
- Akcea Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-12-31 was $82.47M.
- Akcea Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-09-30 was -$31.45M.
- Akcea Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was $41.10M.
- Akcea Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$225.69M.
- Akcea Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was -$121.99M.
- Akcea Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2016 was -$83.16M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | -$48.49M 10-Q · filed 2020-08-05 | -$90.95M 10-Q · filed 2020-08-05 | -$8.48M derived: sum of 3 quarters · filed 2020-08-05 | -$39.93M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2020-03-31 | -$42.46M 10-Q · filed 2020-05-06 | $40.01M derived: sum of 2 quarters · filed 2020-05-06 | $8.56M derived: sum of 3 quarters · filed 2020-05-06 | -$28.85M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-12-31 | $82.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $51.02M derived: sum of 2 quarters · filed 2020-03-02 | $13.62M derived: sum of 3 quarters · filed 2020-08-05 | $41.10M 10-K · filed 2020-03-02 | ||||
| 2019-09-30 | -$31.45M 10-Q · filed 2019-11-06 | -$68.86M derived: sum of 2 quarters · filed 2020-08-05 | -$41.37M 10-Q · filed 2019-11-06 | -$111.97M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-06-30 | -$37.41M 10-Q · filed 2020-08-05 | -$9.92M 10-Q · filed 2020-08-05 | -$80.51M derived: sum of 3 quarters · filed 2020-08-05 | -$144.10M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | $27.48M 10-Q · filed 2020-05-06 | -$43.11M derived: sum of 2 quarters · filed 2020-05-06 | -$106.69M derived: sum of 3 quarters · filed 2020-05-06 | -$168.57M derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | -$70.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$134.18M derived: sum of 2 quarters · filed 2020-03-02 | -$196.05M derived: sum of 3 quarters · filed 2020-03-02 | -$225.69M 10-K · filed 2020-03-02 | ||||
| 2018-09-30 | -$63.58M 10-Q · filed 2019-11-06 | -$125.46M derived: sum of 2 quarters · filed 2019-11-06 | -$155.10M 10-Q · filed 2019-11-06 | -$175.04M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | -$61.88M 10-Q · filed 2019-08-07 | -$91.52M 10-Q · filed 2019-08-07 | -$111.46M derived: sum of 3 quarters · filed 2020-03-02 | -$129.23M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | -$29.64M 10-Q · filed 2019-05-09 | -$49.58M derived: sum of 2 quarters · filed 2020-03-02 | -$67.36M derived: sum of 3 quarters · filed 2020-03-02 | -$87.76M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | -$19.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$37.71M derived: sum of 2 quarters · filed 2020-03-02 | -$58.11M derived: sum of 3 quarters · filed 2020-03-02 | -$121.99M 10-K · filed 2020-03-02 | -$110.18M 10-K · filed 2018-02-28 | |||
| 2017-09-30 | -$17.77M 10-Q · filed 2018-11-06 | -$14.23M 10-Q · filed 2017-11-07 | -$38.17M derived: sum of 2 quarters · filed 2018-11-06 | -$102.05M 10-Q · filed 2018-11-06 | -$86.59M 10-Q · filed 2017-11-07 | -$135.89M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | -$20.40M 10-Q · filed 2018-08-07 | -$11.98M 10-Q · filed 2017-08-09 | -$84.28M 10-Q · filed 2018-08-07 | -$72.36M 10-Q · filed 2017-08-09 | -$118.11M derived: sum of 3 quarters · filed 2019-03-01 | -$137.95M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | -$63.88M 10-Q · filed 2018-05-07 | -$97.71M derived: sum of 2 quarters · filed 2019-03-01 | -$117.55M derived: sum of 3 quarters · filed 2019-03-01 | -$131.16M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | -$33.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$53.67M derived: sum of 2 quarters · filed 2019-03-01 | -$67.28M derived: sum of 3 quarters · filed 2019-03-01 | -$83.16M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | -$19.84M 10-Q · filed 2017-11-07 | -$33.44M derived: sum of 2 quarters · filed 2017-11-07 | -$49.33M 10-Q · filed 2017-11-07 | |||||
| 2016-06-30 | -$13.60M 10-Q · filed 2017-08-09 | -$29.49M 10-Q · filed 2017-08-09 | ||||||
| 2015-12-31 | -$61.50M 8-K · filed 2018-09-18 |